Condition
Sleep Disturbances Associated With Menopause
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Elinzanetant
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
2Total
Phase 2 (2)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06728332CompletedPrimary
An Observational Study to Learn More About How Menopause Affects Women's Sleep and How They Are Being Treated for Sleep Problems
NCT06112756Phase 2CompletedPrimary
A Study to Learn About How Elinzanetant Works and How Safe it is in Women Having Sleep Disturbances Associated With Menopause
SYFee4177f9cac24fc79a018ae4457cace3Phase 2Unknown
A study to learn about how elinzanetant works and how safe it is in women having sleep disturbances associated with menopause
Showing all 3 trials
Research Network
Common Treatments
- Elinzanetant2
- No Study Intervention1
Active Sponsors
- Bayer2
- Bayer AG1
- Bayer Consumer Care AG1